☆ 4.5 Article

Impact on glucometric variables and quality of life of the advanced hybrid closed-loop system in pediatric and adolescent type 1 diabetes

JOURNAL OF DIABETES (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Effectiveness and Safety of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes Previously Treated with Continuous Subcutaneous Insulin Infusion and Flash Glucose Monitoring

Noelia Gros Herguido et al.

Summary: This study evaluated the effectiveness and safety of the MiniMed 780G AHCL system in people with type 1 diabetes. The results showed improved blood glucose control and no severe hypoglycemia or other complications after 6 months of system use.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Add to Collection

Article Endocrinology & Metabolism

MiniMed 780G™ in 2-to 6-Year-Old Children: Safety and Clinical Outcomes After the First 12 Weeks

Mari-Anne Pulkkinen et al.

Summary: The safety and impact of the advanced hybrid closed-loop (AHCL) system on glycemic outcome in 2- to 6-year-old children with type 1 diabetes and the diabetes distress of caregivers were evaluated. The study found that after 12 weeks of using the AHCL system, glycemic control in children improved and diabetes distress in caregivers decreased.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Add to Collection

Article Endocrinology & Metabolism

Outcomes of hybrid closed-loop insulin delivery activated 24/7 versus evening and night in free-living prepubertal children with type 1 diabetes: A multicentre, randomized clinical trial

Eric Renard et al.

Summary: This study evaluated the safety and efficacy of hybrid closed-loop insulin delivery in children with type 1 diabetes. Results showed that the 24/7 mode had better outcomes in increasing TIR compared to the E/N mode, with no safety issues observed.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece

Vaia Lambadiari et al.

Summary: This study compared the cost-effectiveness of the Advanced Hybrid Closed Loop MiniMed 780G (AHCL) system versus sensor augmented pump (SAP) system with predictive low glucose management (PLGM) or multiple daily injections (MDI) plus intermittently scanned continuous glucose monitoring (isCGM) in people with type 1 diabetes in Greece. The study found that the MiniMed 780G system is likely to be cost saving compared with the SAP plus PLGM system and cost-effective compared with MDI plus isCGM, providing increased quality-adjusted life expectancy for patients.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Endocrinology & Metabolism

Glycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial

Gregory P. Forlenza et al.

Summary: The study found that using MiniMed (TM) 670G system in Auto Mode improved glycemic outcomes in young children with T1D compared to Manual Mode, including A1C levels, blood glucose control, and minimizing severe hypoglycemia. The results were similar to those seen in older children, adolescents, and adults with T1D using the system for the same duration of time.

PEDIATRIC DIABETES (2022)

Add to Collection

Article Endocrinology & Metabolism

A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes

Marta Bassi et al.

Summary: Tandem Control-IQ and Minimed 780G are the most advanced hybrid closed loop systems for pediatric and adult patients with Type 1 Diabetes (T1D). A comparison study showed that Minimed 780G was more effective in managing hyperglycemia, while Tandem Control-IQ was more effective in reducing time spent in hypoglycemia.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

Julien Da Silva et al.

Summary: The preliminary performance evaluation of the MiniMed 780G system in real-world settings shows that most users are able to achieve good glycemic control and minimize hypoglycemia, indicating the effectiveness of the system.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Endocrinology & Metabolism

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users

Arcelia Arrieta et al.

Summary: This empirical study investigated the real-world glycaemic outcomes and goals achieved by users of the MiniMed 780G advanced hybrid closed loop system in different age groups of type 1 diabetes patients. The results show that both patients aged 15 years or younger and patients aged older than 15 years achieved good blood glucose control with the use of the AHCL system, in line with the international consensus recommendations.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article Endocrinology & Metabolism

Real-world prospective observational single-centre study: Hybrid closed loop improves HbA1c, time-in-range and quality of life for children, young people and their carers

Sze May Ng et al.

Summary: This study evaluated the effectiveness of hybrid closed-loop systems in managing type 1 diabetes and improving quality of life in children and young people. The results showed that the use of hybrid closed-loop systems for 3 months significantly improved glucose control, reduced time in hypoglycemia, and reduced fear and worry of hypoglycemia.

DIABETIC MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus

Basilio Pintaudi et al.

Summary: This study evaluated the effectiveness of the Minimed 780G system in patients with type 1 diabetes. The results showed that the system significantly improved glucose control and reduced the risk of hypoglycemia and glucose variability.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2022)

Add to Collection

Article Endocrinology & Metabolism

Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study

Ulrike Schierloh et al.

Summary: This study compared glycemic control and treatment preference in children with T1D using SAP with SmartGuard (R) or pump with iscCGM. The results showed no significant difference in glycemic control between the two treatments. One year after the study, all families decided to continue using CGM and showed a preference for SmartGuard (R).

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Predictors of time in target glucose range in real-world users of the MiniMed 780G system

Javier Castaneda et al.

Summary: This study aimed to investigate predictors of improved sensor glucose range in diabetes patients using the Minimed 780G system. The findings suggest that optimized pump settings and other modifiable factors play a significant role in achieving glycemic targets.

DIABETES OBESITY & METABOLISM (2022)

Add to Collection

Article

Insulin Requirements for Basal and Auto-Correction Insulin Delivery in Advanced Hybrid Closed-Loop System: 4193 Days’ Real-World Data of Children in Two Different Age Groups

Kağan Ege Karakuş et al.

Journal of diabetes science and technology (2022)

Add to Collection

Article Endocrinology & Metabolism

Long-term outcomes of an advanced hybrid closed-loop system: A focus on different subpopulations

Pilar Isabel Beato-Vibora et al.

Summary: This study prospectively evaluated the long-term benefit of using the advanced hybrid closed-loop system (AHCL) in different subpopulations. The results showed sustained improvement in blood glucose control and hypoglycemia risk with the AHCL system in all subgroups.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Add to Collection

Article Endocrinology & Metabolism

Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable-1-year prospective, observational, two-center study

Sebastian Seget et al.

Summary: The BMI of children and adolescents with T1D treated with an AHCL system remained stable during the 1 year of follow-up, and they maintained recommended glycemic control.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

Pumps that predict and manage low blood glucose are superior to pumps with stand-alone CGM for reducing hypoglycaemia in type 1 diabetes patients in a real-world setting

C. Telliam et al.

Summary: This study found that insulin pumps with automated predictive low-glucose insulin suspension were more effective than stand-alone flash glucose monitoring in reducing hypoglycemic events in a real-world setting. This could benefit patients at risk of hypoglycemia or those lacking in hypoglycemic awareness.

DIABETES & METABOLISM (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Real-world outcomes with different technology modalities in type 1 diabetes

Pilar Beato-Vibora et al.

Summary: This study evaluated the real-world benefits of different treatment modalities for T1D. Results showed that HCL offers the maximum benefit in terms of maintaining time in range and protecting against hypoglycemia.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2021)

Add to Collection

Article Endocrinology & Metabolism

Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes

Pilar Isabel Beato-Vibora et al.

Summary: The study aimed to evaluate the impact of AHCL system implementation on glycemic control in patients with type 1 diabetes. Results showed that after using the AHCL system, patients had significantly increased TIR, reduced time in hyperglycemia, and no significant change in hypoglycemia time.

DIABETES TECHNOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Endocrinology & Metabolism

Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus

Gianluca Tornese et al.

Summary: The study found that patients using the advanced closed-loop system had a decrease in HbA1c within six months, achieved the TIR >70% target earlier and more stably, without increasing hypoglycemia or BMI. Previous users of the standard hybrid closed-loop system did not show significant improvement. Children under the age of 14 and individuals with the worst glycemic control seemed to benefit the most from the advanced closed-loop pumps.

FRONTIERS IN ENDOCRINOLOGY (2021)

Add to Collection

Article Engineering, Biomedical

MiniMedTM780G Insulin pump system with smartphone connectivity for the treatment of type 1 diabetes: overview of its safety and efficacy

Jennifer McVean et al.

Summary: The MiniMed™ 780 G as a second-generation advanced hybrid closed-loop system has shown promising clinical and safety outcomes in initial pivotal trials. Real-world data and longer-term studies are still needed to further validate its effectiveness. The success of AID devices in the future depends on their ease of use and ability to reduce the burden of living with T1D.

EXPERT REVIEW OF MEDICAL DEVICES (2021)

Add to Collection

Article Endocrinology & Metabolism

Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and Their Parents

Erin C. Cobry et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2020)

Add to Collection

Article Endocrinology & Metabolism

Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion

Guy G. Massa et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2019)

Add to Collection

Article Endocrinology & Metabolism

Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes

Marine Halbron et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2019)

Add to Collection

Review Endocrinology & Metabolism

The road from intermittently scanned continuous glucose monitoring to hybrid closed-loop systems. Part B: results from randomized controlled trials

Francesca De Ridder et al.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)

Add to Collection

Review Endocrinology & Metabolism

The road from intermittently scanned glucose monitoring to hybrid closed-loop systems: Part A. Keys to success: subject profiles, choice of systems, education

Francesca De Ridder et al.

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2019)

Add to Collection

Article Endocrinology & Metabolism

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

Monika Reddy et al.

DIABETES TECHNOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Endocrinology & Metabolism

Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion

Jesus Moreno-Fernandez et al.

ENDOCRINOLOGIA DIABETES Y NUTRICION (2018)

Add to Collection

Review Endocrinology & Metabolism

The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes

Veronique Gingras et al.

DIABETES OBESITY & METABOLISM (2018)

Add to Collection

Review Clinical Neurology

The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: A systematic review and meta-analysis

Tatyana Mollayeva et al.

SLEEP MEDICINE REVIEWS (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.